Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 0.8947 USD -11.42%
Market Cap: 42.9m USD

EV/EBIT
Enterprise Value to EBIT

0.2
Current
0.2
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
0.2
=
Enterprise Value
-18m USD
/
EBIT
-74.9m USD
EBIT Growth EV/EBIT to Growth
US
Shattuck Labs Inc
NASDAQ:STTK
Average EV/EBIT: 15.9
0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 898.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
28%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.7
19%
1
US
U
US BioTec Inc
OTC:USBC
Not Available N/A N/A
US
Gilead Sciences Inc
NASDAQ:GILD
14.5
12%
1.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.8 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.5
17%
1.3
AU
CSL Ltd
ASX:CSL
18.5
16%
1.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.4
10%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -322.4 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
0.3
2-Years Forward
EV/EBIT
0.3
3-Years Forward
EV/EBIT
0.2